Created using Figma
Created using Figma
ClinTex is a clinical trials collaboration and information analytics platform that leverages the benefits of distributed ledger technology. The substructure of the ClinTex CTi platform lies simultaneously in the making of an ecosystem that enables interoperability of all clinical testing information views and, by using blockchain technology, the unique aptitude to deliver a secure environs for the storage and investigation of selected historical clinical information views.
Oct 1, 2018
Nov 5, 2018
100% completed
Raised funds - no Data
  • 1 CLX
    0.1 USD
Token Details
Accepted Currencies
Company Details
Registered Country
Additional Details
Platform, Health, Other

About ClinTex

ClinTex is a clinical trials collaboration and data analytics platform that leverages the benefits of distributed ledger technology (blockchain). It uses smart contracts on the Ethereum public blockchain to provide an end to end decentralised solution that incorporates tools to drive collaboration in the sharing of clinical trial data across the industry and significant quality and operational improvements in running clinical trials through advanced clinical data review, insightful operational key performance indicators (KPIs), predictive data analytics and machine learning (AI). The ClinTex Clinical Trials Intelligence Platform (ClinTex CTi) will vastly improve pharmaceutical companies’ operational and clinical effectiveness in setting-up, conducting, overseeing, reviewing, and meeting regulatory standards for clinical trials. The foundation of the ClinTex CTi platform lies simultaneously in the creation of an ecosystem that enables interoperability of all clinical trial data views and, by using blockchain technology, the unique ability to deliver a secure environment for the storage and analysis of selected historical clinical data views. In this way, the ClinTex CTi platform provides the optimum environment to share clinical data views and develop data analytics solutions while addressing the privacy and security concerns of all stakeholders. Through the CTi platform, an ecosystem is created with seven separate decentralised applications. Together these applications will provide valuable clinical insight that leverages the use of novel predictive analytical tools and machine learning for the benefit of Clinical Project Managers, Clinical Trial Physicians, Clinical Data Managers, Pharmacovigilance staff and Site Monitors.

ClinTex Roadmap

  • Q2 2018

  • CTi Data Model Design;
    CTi-OEM Prototype Development.
  • Q3 2018

  • Pre Sale TGE;
    Public TGE.
  • Q4 2018

  • CTi GUI Development (with Integrated CLX Wallet);
    Blockchain Verification of CTi Pre-Processing Data.
  • Q1 2019

  • Blockchain Verification of CTi Pre-Processing Data;
    CTi-OEM DEvelopment.
  • Read More
  • Q2 2019

  • CTi-PDA Development.
  • Q3 2019

  • CTi-PRR Development;
    Migration on-chain of CTiClinical Data Statistical Summaries.
  • Q4 2019

  • CTi-RBM Development;
    CTi-CDV Development.
  • Q1 2020

  • Cti-VMM Development.
  • Q2 2020

  • CTi-SIM Development.
  • Q3-Q4 2020

  • Migration on-chain of the CTi Data Model and CTi Processing Engine,


3 136
30 Days Growth:

ClinTex Team

Verified 9%

Attention. There is a risk that unverified members are not actually members of the team

Neill Barron
Director of Clinical Data Services
Brendan O’Mainnin
Director of Operations
Samandip Dhesi
Medical Officer
Adrian W. Donoghue
Director of Business Services
John McCabe
Head of Legal & Regulatory
Edward Burke
Lead Developer
Stanislav Sheliakin
Lead DLT Business Architect
Sean Flanagan
Head of Business Development
Ethan Diamant
Head of Clinical Services
Philip O’Neill
Front End UX/UI
Graham Stone
Content Creator


Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Sheraz Majeed
Medical Technology Advisor


$3 082 361

Binod Nirvan
Blockchain Technology Advisor
Stefan Bergström
Strategic Business Advisor


$3 922 763

Ihor Pidruchny
Blockchain Development Advisor
Ciara Barron
Pharmaceutical Development Advisor
Sean Comiskey
Technology Engineering Advisor
Dylan Costigan
Security Engineering Advisor
Omar Zerafa
Legal Advisor

ClinTex Interviews

Brendan O’Mainnin
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
CTi is the first blockchain enterprise solution that will tackle a critical and current problem in the world with regard to the high cost of medical treatments as a result of clinical trial expenditure.
As a team member, сan you tell us about your role in the ICO project?
I oversee all day-to-day administrative and operational functions of the business, the management of all marketing initiatives and the design of operational strategy for ClinTex.
What do you think about idea?
Pharmaceutical companies can now gain deep insight into the operational and clinical aspects of their trials without the necessity of major investment into backend technical infrastructure or data science expertise

ClinTex Last News

5.0 0
ICO Profile Vision Activity Potential Product Team

ClinTex Reviews
ICO review website

There is enough material to suggest that ClinTex is aiming to address a real need within the clinical trial field. Tokenomics for the project are straightforward with minimal bonuses applicable and a clear team vesting period. The acceptance of Binance coin in the ICO adds another level of interest and, although no partnership is stated or implied, investors may feel it increases the possibility of a future listing opportunity with the exchange.

Maybe most importantly, an able team is backed by experienced advisors and together they have shown the foresight to partner with useful allies within the blockchain arena and realm of medical services.

The downside column is much shorter but it should be noted that there is currently no working product and the roadmap suggests that some of the infrastructure will not be fully available until well into 2020 which could hamper uptake of the platform.

The whitepaper states that one of the reasons ClinTex ClinTex has partnered with Intellimed is that they will “…deploy the CTi platform in academic clinical research settings.”

This suggests that a firm footing for the initial launch of the platform has been established so it is the forward momentum of ClinTex, that includes expected on-boarding of other pharmaceutical companies in mid-2019, that contributors to the ICO will need to judge.

Given that they have first mover advantage in this particular specialised arena, the fundamentals appear to outweigh the minor concern and marks ClinTex as an ICO worthy of serious consideration.

Read More
  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.
Planning an ICO? We can help with a wide range of support for all stages of your ICO